relapsed
Showing 6526 - 6550 of 7,775
NSCLC Trial in Canada, Germany, United States (imetelstat, Bevacizumab)
Completed
- Non-small Cell Lung Cancer
-
Birmingham, Alabama
- +32 more
Dec 22, 2015
Mantle Cell Lymphoma Trial in Augusta (Panobinostat, Bortezomib)
Completed
- Mantle Cell Lymphoma
-
Augusta, GeorgiaGeorgia Regents University
Sep 18, 2014
Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Trial in Boston, Lebanon (P1446A-05)
Suspended
- Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
-
Boston, Massachusetts
- +1 more
Sep 2, 2014
Cervical Cancer Trial in Paris (carboplatin, topotecan HCl)
Completed
- Cervical Cancer
- carboplatin
- topotecan hydrochloride
-
Paris, FranceHotel Dieu de Paris
Oct 28, 2014
Lymphoma, Large-Cell, Diffuse Trial in Worldwide (OFATUMUMAB + DHAP, RITUXIMAB + DHAP)
Completed
- Lymphoma, Large-Cell, Diffuse
- OFATUMUMAB + DHAP
- RITUXIMAB + DHAP
-
Sacramento, California
- +172 more
Jul 9, 2015
Gastric Cancer Trial in Busan (irinotecan, oxaliplatin, oxaliplatin, irinotecan)
Completed
- Gastric Cancer
- irinotecan, oxaliplatin
- oxaliplatin, irinotecan
-
Busan, Korea, Republic ofSung Yong Oh
Nov 2, 2014
Bladder Carcinoma, Breast Cancer, Esophagus Carcinoma Trial in Shenzhen (Cyclophosphamide, Fludarabine, Anti-NY ESO-1
Unknown status
- Bladder Carcinoma
- +9 more
- Cyclophosphamide
- +2 more
-
Shenzhen, Guangdong, ChinaShenzhen Second People's Hospital, The First Affiliated Hospital
Aug 1, 2016
Multiple Myeloma Trial in Durham (Bortezomib, Melphalan, Prednisone)
Completed
- Multiple Myeloma
- Bortezomib
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Mar 21, 2016
Lymphoma, Low-Grade, Lymphoma, Small Lymphocytic, Lymphoma, Mixed-Cell, Follicular Trial in United States (Pixantrone (BBR
Completed
- Lymphoma, Low-Grade
- +3 more
- Pixantrone (BBR 2778)
- +3 more
-
Tucson, Arizona
- +3 more
Jan 15, 2015
Sarcoma Trial in Philadelphia (aldoxorubicin)
No longer available
- Sarcoma
-
Philadelphia, PennsylvaniaThomas Jefferson University
Oct 21, 2015
Chronic Hepatitis C Trial in Minato-ku (MP-424 (generic name:Telaprevir), Ribavirin, Peginterferon alfa-2b)
Completed
- Chronic Hepatitis C
- MP-424 (generic name:Telaprevir)
- +2 more
-
Minato-ku, Tokyo, JapanToranomon Hospital
Oct 29, 2014
Breast Cancer Trial in Chai Yi, Kaohsiung, Taipei (capecitabine [Xeloda], trastuzumab [Herceptin])
Terminated
- Breast Cancer
- capecitabine [Xeloda]
- trastuzumab [Herceptin]
-
Chai Yi, Taiwan
- +5 more
Dec 15, 2014
Peripheral T-cell Lymphomas Trial in Nanjing City (GDP, Endostar)
Unknown status
- Peripheral T-cell Lymphomas
- GDP
- Endostar
-
Nanjing City, Jiangsu, ChinaJiangsu province tumor hospital
Aug 6, 2015
Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Trial in Shimotsuke (Cyclophosphamide or Bendamustine, Dose Level -1, Dose
Unknown status
- Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
- Cyclophosphamide or Bendamustine
- +4 more
-
Shimotsuke, Tochigi, JapanJichi Medical University
Nov 4, 2014
Peripheral T-cell Lymphoma Trial in Seoul (SP-02L (darinaparsin for injection))
Completed
- Peripheral T-cell Lymphoma
- SP-02L (darinaparsin for injection)
-
Seoul, Korea, Republic ofSamsung Medical Center
Sep 3, 2014
Multiple Myeloma and Plasma Cell Tumor Trial in Ireland, United Kingdom (Bortezomib, Doxorubicin, Dexamethasone)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- Bortezomib
- +2 more
-
Dublin, Ireland
- +8 more
Dec 30, 2014
Treatment-naïve Chronic Hepatitis C Treated With Pegasys or
Completed
- Hepatitis C, Chronic
- Peginterferon alfa-2a [Pegasys]
- Peginterferon alfa-2b [PegIntron®]
-
Aalst, Belgium
- +100 more
Apr 4, 2016
Carcinoma, Renal Cell, Lymphoma, Non-Hodgkin Trial in United States (SGN-75)
Completed
- Carcinoma, Renal Cell
- Lymphoma, Non-Hodgkin
-
Birmingham, Alabama
- +8 more
Dec 17, 2014
Chronic Leukemia, Acute Leukemia, Hodgkin's Disease Trial in Atlanta (Peripheral Blood Stem Cell Transplant)
Completed
- Chronic Leukemia
- +4 more
- Peripheral Blood Stem Cell Transplant
-
Atlanta, GeorgiaNorthside Hospital
Dec 10, 2015